SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

High Roller Technologies, Inc. is an evolving and growth-oriented iCasino and entertainment company, which engages in the business of operating an online gaming business offering casino betting games to customers. The firm also offers a wide range of games including many that are available in land-based casinos, such as blackjack, roulette, baccarat, poker, and slot machines. The company was founded by Michael Alexander Cribari and Brandon Christopher Eachus on December 21, 2021 and is headquartered in Las Vegas, NV.

High Roller Technologies Inc.

High Roller Technologies Inc

High Roller Technologies (ROLR) is trending on news of its strategic partnership with crypto.com/us to enter the rapidly expanding US event-based prediction markets, a sector estimated for substantial annual trading volume. The community is highly engaged, anticipating significant price movements fueled by the low float and potential for a short squeeze, reflecting bullish sentiment on the future of online gambling and crypto-enabled platforms.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amid reports of a revised all-cash offer for Warner Bros. Discovery's studio and streaming assets, a move seen by many as a strategic effort to eliminate shareholder dilution and secure the deal against competing bids. The community is sharply divided, with some viewing this as a bullish sign of confidence in upcoming earnings and a path to media empire expansion, while others voice concerns about increased debt and potential overvaluation. This development, coupled with anticipation for the impending earnings report, is driving extensive discussion around the stock's immediate future.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending with significant community discussion ahead of its J.P. Morgan Healthcare Conference presentation, fueled by a high short interest and anticipation of a potential squeeze. Investors are keenly focused on announcements regarding new partnerships for its Matrix-M adjuvant, particularly in oncology and other infectious diseases, amidst a wave of M&A activity across the biotech sector.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

Cleanspark is trending following its definitive agreement to acquire significant land and transmission facilities in Texas for a large-scale data center, marking a strategic expansion into AI and high-performance computing. Community discussion centers on the immense growth potential this move presents, though some investors remain cautious, awaiting concrete AI customer deals to validate the new infrastructure investments.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending following strong preliminary revenue and optimistic guidance for its MS drug Briumvi, which is driving substantial community discussion. Many traders believe the biotech is significantly undervalued and poised for future growth toward blockbuster status, despite ongoing market volatility and active short interest. Enthusiasm is also fueled by expectations for further pipeline developments in the competitive multiple sclerosis treatment landscape.

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSI Technology is seeing significant buzz driven by its Gemini-II APU, with recent news of a government-funded proof-of-concept for Edge AI autonomous security systems and upcoming presentations at the Needham Growth Conference. The community is sharply divided; while bulls highlight its low-power, compute-in-memory AI for defense and drone applications and anticipate major contracts, skeptics point to historical losses, dilution, and previous product failures. This heightened interest reflects a broader market focus on efficient AI inference solutions, where GSIT aims to differentiate its technology from power-hungry alternatives.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is actively discussed after committing to absorb the electricity costs for its expanding AI data centers, aiming to alleviate concerns about rising consumer utility bills and regulatory scrutiny. This development frames broader community debate on the company's AI monetization strategy and cloud growth, with many investors anticipating whether upcoming earnings will drive a significant rebound amidst its recent market underperformance.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing a significant surge, primarily driven by Bitcoin's strong rally and a potent short squeeze narrative dominating community discussions. Investors are actively watching MSTR as a leveraged proxy for Bitcoin, with many anticipating continued upside as its substantial digital asset treasury gains value.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is currently trending as Bitcoin demonstrates renewed strength and the community anticipates progress on the "Clarity Act" crypto bill in the Senate, which could provide significant regulatory certainty. While bulls anticipate substantial upside driven by recent analyst upgrades and Coinbase's expanding product offerings like tokenization, many express frustration over its perceived underperformance relative to Bitcoin's rallies and ongoing market volatility. The confluence of crypto market momentum and potential regulatory clarity fuels intense debate and investor interest around the stock.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical ($DRTS) is drawing significant attention with multiple catalysts converging, including high anticipation for a potential PMDA approval in Japan and a presentation at the J.P. Morgan Healthcare Conference. The community is buzzing over recently released positive pancreatic cancer data and an FDA submission, alongside increasing institutional interest and robust trading volume, despite some discussion around bot activity. This targeted alpha radiation therapy is seen as a revolutionary, undervalued opportunity in the active biotech sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing, and provision of technologies, and services in the cell and gene therapy industry. It operates through the following segments: Octomera and Therapies. The Octomera segment refers to the point of care services. The Therapies segment is involved in therapeutic development operations. The company was founded by Sarah Ferber on June 5, 2008 and is headquartered in Germantown, MD.

Orgenesis Inc

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

Current Price	$0.15
Prev Close	$0.15
Open	$0.15
Dividend Yield	N/A
50-Day Moving Average	$0.3754
Beta	548.17
Avg. Volume	2,567.23
PE Ratio	N/A

52-Week High	$5.89
52-Week Low	$0.0001
Market Capitalization	$814,701.00
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

ORGS
Orgenesis Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ORGS News

ORGSOrgenesis Inc